US Stock MarketDetailed Quotes

BRTX Biorestorative Therapies

Watchlist
  • 1.995
  • -0.295-12.88%
Close Feb 18 16:00 ET
  • 2.070
  • +0.075+3.76%
Post 19:05 ET
13.81MMarket Cap-1.40P/E (TTM)
Post-Market
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Comments

    Jaguar8
    Jaguar8
    Feb 10 06:17
    NEWS
    $Biorestorative Therapies (BRTX.US)$
    BRTX-100 Front and Center at ORS 2025
    BioRestorative Therapies (NASDAQ:BRTX) presented new blinded preliminary data from its Phase 2 clinical trial of BRTX-100 at the Orthopaedic Research Society annual meeting. The data, now covering 15 patients with chronic lumbar disc disease (cLDD), showed significant improvements:
    - Pain reduction (VAS): 71.20% at 26 weeks and 73.58% at 52 weeks
    - Function improvement (ODI): 69.04% at 26 weeks and 65.16% at 52 weeks
    -...
    Trytosaveabit
    Trytosaveabit
    Feb 10 06:15
    update
    $Biorestorative Therapies (BRTX.US)$ BRTX-100 Front and Center at ORS 2025
    GlobeNewswire· 9 mins ago
    – New blinded preliminary BRTX-100 data described this past Saturday at prestigious "2025 Winners in Industry Innovations in MSK Health" presentation –
    – Among other positive preliminary data analyses, comparison of MRI images to baseline potentially demonstrate disc microenvironment remodeling –
    MELVILLE, N.Y., Feb. 10, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorativ...
    Trytosaveabit
    Trytosaveabit
    Dec 5, 2024 05:46
    News
    $Biorestorative Therapies (BRTX.US)$ Reuters
    Just
    BioRestorative Therapies Announces Notice of Allowance of Key New Patent Protecting Thermostem® Metabolic Disease Program
    2
    Jaguar8
    Jaguar8
    Dec 5, 2024 05:45
    NEWS
    $Biorestorative Therapies (BRTX.US)$
    BioRestorative Therapies Announces Notice of Allowance of Key New Patent Protecting ThermoStem® Metabolic Disease Program
    Thursday, 5th December at 6:45 am
    – Covers cGMP manufacturing processes –
    – Expected to provide protection until April 29, 2040 –
    MELVILLE, N.Y., Dec. 05, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative", "BRTX" or the "Company") (NASDAQ: BRTX), a clinical stage regenerative medicine innovator focused on stem...
    Jaguar8
    Jaguar8
    Nov 13, 2024 06:05
    NEWS
    $Biorestorative Therapies (BRTX.US)$
    BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data
    5 minutes ago, 4:00 AM PST
    Via GlobeNewswire
    – Blinded preliminary data demonstrate a positive trend and clear signal in Primary and Secondary endpoints –
    – Patient reported efficacy outcomes show a material decrease in pain and increase in function –
    – If positive trends continue, Company confident that the Phase 2 trial will meet its Primary and Secondary end points -
    ...
Read more

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
HENDERA
831152
+30.00%
Hengerda New Materials
300946
+20.01%
Fujian Nebula Electronics.,Ltd
300648
+20.00%
4
Cubic Digital Technology
300344
+19.98%
5
HNAC Technology
300490
+19.95%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More
FOMC Press Conference, January 29, 2025